Emergence Therapeutics is a European biopharmaceutical company developing novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. The lead program features innovative antibody design as well as state of the art linker and payload technology to target Nectin-4 – an important and validated target for a broad range of cancers.
Year of investment
2021
Sector
Drug development
Location
Duisburg, Germany
Website
http://emergencetx.com/
Location: Germany, North Rhine-Westphalia, Duisburg
Total raised: $98.47M
Investors 5
| Date | Name | Website |
| - | Kurma Part... | kurmapartn... |
| 28.12.2021 | Hadean Ven... | hadeanvent... |
| - | Gründerfon... | gruenderfo... |
| 17.07.2021 | High-Tech ... | htgf.de |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.12.2021 | Series A | $98.47M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 21.12.2023 | Hadean Ventures announces oversubscribed final close of Hade... | Hadean Ventures announces oversubscribed final close of Hadean Capital II – a fund dedicated to inve... | hadeanvent... |
| 09.10.2023 | Who are the Pioneers of Germany’s Innovative Fitness Startup... | There’s no denying that health and wellness has become an integral part of our daily lives. Thanks t... | eustartup.... |
| 19.09.2023 | Who are Nordrhein-Westfalen’s Top Health Care Innovators Cha... | Welcome to our revelatory piece dedicated to shining a light on a collective of astounding Health Ca... | eustartup.... |
| 20.06.2023 | Biotech Breakthroughs: Unraveling Germany’s 15 Emerging Biot... | Emergence Therapeutics led by Jack Elands, is a promising biopharmaceutical company dedicated to adv... | eustartup.... |
| 14.12.2021 | Emergence Therapeutics Secures €87M in Series A Financing | Emergence Therapeutics AG, a Duisburg, Germany-based biopharmaceutical company developing novel anti... | finsmes.co... |
| 10.12.2021 | Emergence Therapeutics raises €87 million Series A financing... | Duisburg, Germany, 7 December 2021. Emergence Therapeutics AG, a biopharmaceutical company developin... | hadeanvent... |
| 07.12.2021 | Emergence Therapeutics raises €87 million Series A financing... | Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC Series A round ... | globenewsw... |
| - | Emergence Therapeutics raises €87 million Series A financing... | December 7, 2021 | htgf.de/en... |
| - | Emergence Therapeutics Announces a Bumped-up Follow-on Seed ... | Emergence Therapeutics AG, a European biopharmaceutical company developing novel antibody drug conju... | htgf.de/en... |